Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:myeloid leukemia incidence/prevalence measurement
go back to main search page
Accession:CMO:0002275 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display myeloid leukemia, a form of leukemia characterized by the increased and unregulated growth of predominantly myeloid (that is, non-lymphocytic) cells in the bone marrow and the accumulation of these cells in the bone marrow and/or blood, at a point in time or develop myeloid leukemia within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.
Synonyms:xref: MESH:D007951



show annotations for term's descendants           Sort by:
 

Term paths to the root